Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H12FN5O3 |
| Molecular Weight | 269.2324 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC2=C(N=CN2[C@H]3C[C@H](F)[C@@H](CO)O3)C(=O)N1
InChI
InChIKey=RTJUXLYUUDBAJN-KVQBGUIXSA-N
InChI=1S/C10H12FN5O3/c11-4-1-6(19-5(4)2-17)16-3-13-7-8(16)14-10(12)15-9(7)18/h3-6,17H,1-2H2,(H3,12,14,15,18)/t4-,5+,6+/m0/s1
| Molecular Formula | C10H12FN5O3 |
| Molecular Weight | 269.2324 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Profound antiviral effect of oral administration of MIV-210 on chronic hepadnaviral infection in a woodchuck model of hepatitis B. | 2009-09 |
|
| In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2',3'-dideoxy-3'-fluoroguanosine. | 2006-03 |
|
| In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase. | 2005-03 |
|
| Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus. | 2000-11 |
|
| Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivo. | 1996-03 |
|
| Enhanced in vitro inhibition of HIV-1 replication by 3'-fluoro-3'-deoxythymidine compared to several other nucleoside analogs. | 1988-12 |
|
| Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3'-fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus. | 1988-03 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:23:47 GMT 2025
by
admin
on
Wed Apr 02 09:23:47 GMT 2025
|
| Record UNII |
UU109JJU0U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C97452
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9105
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
UU109JJU0U
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
C90784
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
135431817
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
300000036985
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
92562-88-4
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY | |||
|
DTXSID90239044
Created by
admin on Wed Apr 02 09:23:47 GMT 2025 , Edited by admin on Wed Apr 02 09:23:47 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PRODRUG -> METABOLITE ACTIVE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|